T
TheraTrue
A Georgia-based company focused on improving lives through innovation in the medical cannabis industry
About TheraTrue
TheraTrue is a medical cannabis startup, primarily aimed at improving the lives of patients through innovative and quality products. The company operates in the burgeoning medical cannabis market, serving patients who require cannabis for medical purposes. TheraTrue's business model is centered around the production and distribution of medical cannabis products, leveraging the expertise of its diverse team of professionals from across the cannabis industry.
The company is well-funded, with $50 million in funding commitments, which provides a solid financial foundation for its operations. This capital is primarily utilized in the production of high-quality medical cannabis products, which is the company's primary revenue stream. TheraTrue's commitment to quality is further evidenced by its medical advisory board, which comprises over 20 physicians and pharmacists. This ensures that the products are not only effective but also safe for patient use.
TheraTrue also prides itself on its commitment to diversity. It is a majority black-owned company, with a board and management team that are predominantly people of color. This diversity is not just about representation, but also about bringing a variety of perspectives and experiences to the table, which can lead to more innovative solutions and better decision-making.
In conclusion, TheraTrue is a well-capitalized medical cannabis company that is committed to improving patient lives through quality products, innovation, and diversity.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Brookhaven, United States
- Employees
- 4
- Open positions
- 1
- Dealroom signal
- 28.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Cannabis, Tech for Patients, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Feb 2021 | $50M | $200M | Undisclosed | — |
Growth signals
Latest recorded traffic for TheraTrue is 290 monthly website visits, up 81.3% over the last three months. TheraTrue's team declined 33.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about TheraTrue on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TheraTrue’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







